Monocolonal Antibody Might Help Prevent Malaria

Johanna Daily, M.D., M.S., comments on a study that found a lab-engineered antibody effective in protecting most participants from malaria infection. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.

Additional coverage includes UPI, MedPage Today


Effects of COVID-19 on the Brain

Michael Lipton, M.D., Ph.D., and Johanna Daily, M.D., M.S., discuss their National of Institutes Health grant to study how COVID-19 affects brain function in young adults who had mild or asymptomatic infection. Dr. Lipton is associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.


‘Will You Help Save My Brother?’: The Scramble to Find COVID-19 Plasma Donors

Johanna Daily, M.D., M.S., discusses the effort to screen the blood of people who have recovered from COVID-19 and the potential to use their antibodies to help others who may have the disease. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.

Additional coverage of Dr. Daily on COVID-19 includes: CBSNewYork, ABC7NewYork and USA Today (video)


NPR interviews Johanna Daily, M.D., about the new, modestly effective RTS,S malaria vaccine that reduced disease in children by 27-46 percent. Dr. Daily notes that while higher efficacy rates are desirable, malaria is a particularly challenging disease that researchers have struggled to prevent. She explains that each country that battles with malaria will have to choose how to spend their limited resources – on this vaccine, protective nets, community health workers or other options. Dr. Daily is associate professor of medicine and of microbiology & immunology.


NPR interviews Johanna Daily, M.D., about the disappointing results of a malaria vaccine for infants, which only lowered risk of disease by a third. Dr. Daily notes that malaria parasites are particularly adept at hiding from the immune system because they reside where the immune cells are – in the blood.

More coverage on this story

Bloomberg News